Marpai (MRAI)
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party ad...
- Open
- 2.010
- High
- 2.380
- Low
- 2.010
- Prev. Close
- 1.978
- Volume
- 173.16K
- Turnover
- 383.24K
- Avg Price
- 2.213
- Bid/Ask Ratio
- --
- Amplitude
- 18.71%
- 52wk High
- 2.500
- Volume Ratio
- 0.46
- Turnover Ratio
- 1.24%
Marpai Analyst Rating
View moreForecast & Rating
May 10, 2024Price forecast
$6.00157.51%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 17 at 08:01 AM
Claritev expands Marpai partnership to add pre- and post-payment claims integrity services
- businessinsider · Aug 13 at 04:56 PM
Marpai GAAP EPS of -$0.18, revenue of $4.17M
- Quartr · Aug 13 at 03:31 PM
MRAI: Q2 2026 revenue fell 10.5% to $4.2M, with a $4.6M net loss and ongoing liquidity concerns
- PUBT · Aug 13 at 03:27 PM
Marpai Q2 FY26 net loss narrows 35.7% to $0.18 a share; revenue falls 10.5% to $4.17 million
- StockTitan · Aug 13 at 08:48 AM
Marpai Reports Second Quarter 2026 Financial Results | MRAI Stock News
- PUBT · Jul 31 at 04:30 PM
Marpai enters $12 million private placement of convertible preferred stock led by Mitchell Companies
